Chronic inflammatory activation of arterial endothelial cells in mice under normal lipoprotein/cholesterol levels and on normal diet.
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus
PROVIDER: GSE230566 | GEO | 2024/05/07
REPOSITORIES: GEO
Similar Datasets
Project description:Chronic inflammatory activation of arterial endothelial cells in mice under normal lipoprotein/cholesterol levels and on normal diet.
| PRJNA961776 | ENA
Project description:While much progress has been made in identifying the mechanisms that trigger endothelial activation and inflammatory cell recruitment during atherosclerosis, less is known about the intrinsic pathways that counteract these events. Here we identified NOTCH1 as an antagonist of endothelial cell activation. NOTCH1 was constitutively expressed by adult arterial endothelium, but levels were significantly reduced by high fat diet. Furthermore, treatment of human aortic endothelial cells (HAEC) with inflammatory lipids (Ox-PAPC) and pro-inflammatory cytokines (TNFalpha and IL1beta) decreased Notch1 expression and signaling in vitro through a mechanism that requires STAT3 activation. Reduction of NOTCH1 in HAEC by siRNA, in the absence of inflammatory lipids or cytokines, increased inflammatory molecules and binding of monocytes. Conversely, some of the effects mediated by Ox-PAPC were reversed by increased NOTCH1 signaling; suggesting a link between lipid-mediated inflammation and Notch1. Interestingly, reduction of NOTCH1 by Ox-PAPC in HAEC was associated with a genetic variant previously correlated to HDL in a human GWAS. Finally endothelial Notch1 heterozygous mice showed higher diet-induced atherosclerosis. Based on these findings, we propose that reduction of endothelial NOTCH1 is a predisposing factor in the onset of vascular inflammation and initiation of atherosclerosis. Transcript profile from Human Aortic Endothelial Cells (HAEC) transfected with siRNA targeting NOTCH1 (n=3) or treated with Ox-PAPC (Oxidized 1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PhosphoCholine) for 6 hours (n=3) were compared to control HAEC (transfected with control siRNA and control media; n=3).
2015-10-26 | E-GEOD-72633 | biostudies-arrayexpress
Project description:While much progress has been made in identifying the mechanisms that trigger endothelial activation and inflammatory cell recruitment during atherosclerosis, less is known about the intrinsic pathways that counteract these events. Here we identified NOTCH1 as an antagonist of endothelial cell activation. NOTCH1 was constitutively expressed by adult arterial endothelium, but levels were significantly reduced by high fat diet. Furthermore, treatment of human aortic endothelial cells (HAEC) with inflammatory lipids (Ox-PAPC) and pro-inflammatory cytokines (TNFalpha and IL1beta) decreased Notch1 expression and signaling in vitro through a mechanism that requires STAT3 activation. Reduction of NOTCH1 in HAEC by siRNA, in the absence of inflammatory lipids or cytokines, increased inflammatory molecules and binding of monocytes. Conversely, some of the effects mediated by Ox-PAPC were reversed by increased NOTCH1 signaling; suggesting a link between lipid-mediated inflammation and Notch1. Interestingly, reduction of NOTCH1 by Ox-PAPC in HAEC was associated with a genetic variant previously correlated to HDL in a human GWAS. Finally endothelial Notch1 heterozygous mice showed higher diet-induced atherosclerosis. Based on these findings, we propose that reduction of endothelial NOTCH1 is a predisposing factor in the onset of vascular inflammation and initiation of atherosclerosis.
2015-10-26 | GSE72633 | GEO
Project description:Human Arterial Endothelial Cells (HAECs; Lonza) were incubated with either 5mg/dl or 100mg/dl isolated lipoprotein(a) for 6 hours. Next, RNA was isolated (RIN>9) and processed for NGS. NGS details: Sequencing of RNA (rRNA depleted), HiSeq4000, Paired-End, 150 bp
2020-05-26 | GSE145898 | GEO
Project description:Inflammatory activation of endothelial cells is considered to be the first step in the development of atherosclerosis. Here, we determined the consequences of chronic endothelial NF-κB activation on the development and progression of atherosclerosis as well as plaque regression.
2020-06-28 | GSE150698 | GEO
Project description:Ikk2-mediated inflammatory activation of arterial endothelial cells promotes the development and progression of atherosclerosis
| PRJNA633170 | ENA
Project description:Objective: Disturbed blood flow characterized by low and oscillatory shear stress and complex microenvironment is one of the causes of the atherosclerosis progression. During the development, endothelial cells generally develop into a dysfunction state, so do other cells. To further analyze the heterogeneity of different cell types, single-cell RNA sequencing was used to provide detailed transcriptomic information.</p><p>Approach and results: Transcriptional analysis of single cells from aortic arch of 16-week Apoe-/- mice under normal and atherosclerotic condition was carried out using single-cell RNA sequencing. By unsupervised clustering, 10 types of cells were identified: endothelial cells, immune cells, fibroblasts, erythroids, smooth muscle cells, cycling basal cells, clara cells, mesothelial cells, adipocytes and neurons. Among these cells, endothelial cells and immune cells exhibited great heterogeneity especially between normal and atherosclerotic group. Gene expression profile of later screened cells identified ten subpopulations of endothelial cells of different functions. Distribution of these cells in the control group and HFD group varies. Immune cells consist of macrophages, foam cells, B cells, T cells, neutrophils and NK cells mainly. During the data processing, the cell sorting is done by recognition with specific markers and rules.</p><p>Conclusions: Our data provide a comprehensive description of all kinds of cells in aortic arch and the heterogeneity brought by western diet. These findings open a new sight into the transcriptional development of atherosclerosis.
2022-12-31 | GSE206239 | GEO
Project description:Effect of lipoprotein(a) on Arterial Endothelial Cells
| PRJNA608696 | ENA
Project description:Cardiovascular (CV) disease is a leading cause of morbidity and mortality in Western societies. Even after accounting for traditional CV risk factors (e.g. obesity, smoking and hypertension), the inflammation-driven thickening and stiffening of central arteries is a strong predictor of adverse outcomes. Arterial wall changes are universally associated with advancing age and show unparalleled worsening in metabolic syndrome. In mice, resveratrol ameliorates a high-fat diet induced arterial wall inflammation and slows age-associated physiologic deteriorations within the arterial wall. Here we tested resveratrol in adult male rhesus monkeys, an experimental model relevant to humans. A diet rich in fat and sucrose (HFS) led to an increase in body weight as well as thickening and stiffening of the aortic wall, marked by diffuse inflammation, fibrosis and fat infiltration. Dietary resveratrol supplementation prevented diet-induced structural and functional alterations within the aortic wall, and abrogated the deleterious vascular endothelial and smooth muscle responses. Integrative genomic and proteomic analyses of aortic tissues revealed molecular signatures consistent with improved vascular functions. Thus, resveratrol conferred protection against the initiation of diet-induced inflammatory events that progress to pathological thickening and stiffening of large arteries. Dietary resveratrol may therefore hold promise as a novel therapy to ameliorate metabolic stress-induced CV disease. After baseline assessment, four male rhesus monkeys remained on the healthy standard diet (SD), 10 male rhesus monkeys were begun on a high fat/high sucrose (HFS) diet and 10 male rhesus monkeys were begun on a high fat/high sucrose (HFS) diet plus Resveratrol, 80mg/day. After one year of dietary intervention, the amount of resveratrol was increased to 240mg/day for one additional year. Tissues were then harvested for the array experiments.
2014-07-21 | E-GEOD-45927 | biostudies-arrayexpress
Project description:Cardiovascular (CV) disease is a leading cause of morbidity and mortality in Western societies. Even after accounting for traditional CV risk factors (e.g. obesity, smoking and hypertension), the inflammation-driven thickening and stiffening of central arteries is a strong predictor of adverse outcomes. Arterial wall changes are universally associated with advancing age and show unparalleled worsening in metabolic syndrome. In mice, resveratrol ameliorates a high-fat diet induced arterial wall inflammation and slows age-associated physiologic deteriorations within the arterial wall. Here we tested resveratrol in adult male rhesus monkeys, an experimental model relevant to humans. A diet rich in fat and sucrose (HFS) led to an increase in body weight as well as thickening and stiffening of the aortic wall, marked by diffuse inflammation, fibrosis and fat infiltration. Dietary resveratrol supplementation prevented diet-induced structural and functional alterations within the aortic wall, and abrogated the deleterious vascular endothelial and smooth muscle responses. Integrative genomic and proteomic analyses of aortic tissues revealed molecular signatures consistent with improved vascular functions. Thus, resveratrol conferred protection against the initiation of diet-induced inflammatory events that progress to pathological thickening and stiffening of large arteries. Dietary resveratrol may therefore hold promise as a novel therapy to ameliorate metabolic stress-induced CV disease.
2014-07-21 | GSE45927 | GEO